CLINICAL_TRIALS
trial_result
· 2017-01-11
Clinical Trial Update: Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD) [Phase 2]
Summary
A Phase 2 safety and efficacy study comparing ETS6103 with amitriptyline in adults with major depressive disorder has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: e-Therapeutics PLC | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-01-11